Abivax Provides Business and Operational Update

ABTECT Phase 3 Global Clinical Trial Enrollment Progressing as Planned; Induction and Maintenance Data Readouts Expected in Q1 2025 and Q1 2026, RespectivelyDurability of Efficacy Results with No New Safety Signals Observed in Step-Down Dosing from …